NCT04866888 Placenta Accreta Spectrum Outcome After Uterine Conservation
| NCT ID | NCT04866888 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Alexandria University |
| Condition | Placenta Accreta Spectrum |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2021-04-28 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2021-04-28 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
study will be carried out on patients with placenta accreta spectrum having done uterine conservation and recording immediate outcome of conservation regarding success of the procedure, amount of blood loss and amount of blood transfused and followed up to check the return of menses, any uterine abnormalities by ultrasound or hysteroscopy especially isthmocele and intrauterine synechia.
Eligibility Criteria
Inclusion Criteria: * • Diagnosed sonographically to have placenta accreta spectrum. * Pregnancy is singleton and fetus is alive. * Elective caesarean section done from 35 gestational weeks. Exclusion Criteria: * • Patients requesting hysterectomy. * Coexisting uterine pathology such as fibroids or gynaecological malignancies. * Patients with bleeding diathesis. * Morbid obesity of BMI \>40. * Patients having labour pains or vaginal bleeding before scheduled intervention.
Contact & Investigator
Mervat S Al-sedik, MD
STUDY CHAIR
faculty of medicine department of obstetrics and gyneacology
Frequently Asked Questions
Who can join the NCT04866888 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 40 Years, studying Placenta Accreta Spectrum. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04866888 currently recruiting?
Yes, NCT04866888 is actively recruiting participants. Contact the research team at o_kamal13@alexmed.edu.eg for enrollment information.
Where is the NCT04866888 trial being conducted?
This trial is being conducted at Alexandria, Egypt.
Who is sponsoring the NCT04866888 clinical trial?
NCT04866888 is sponsored by Alexandria University. The principal investigator is Mervat S Al-sedik, MD at faculty of medicine department of obstetrics and gyneacology. The trial plans to enroll 120 participants.